These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39208959)

  • 1. Evaluation of the efficacy of Chitosan nanoparticles based on Rosuvastatin in the treatment of acute toxoplasmosis: An In vitro and In vivo study.
    Norouzi M; Niyyati M; Ghorbani-Bidkorpeh F; Javadi Mamaghani A; Seyyed Tabaei SJ
    Microb Pathog; 2024 Oct; 195():106897. PubMed ID: 39208959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
    Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin reduced brain parasite burden in a chronic toxoplasmosis
    Nishi L; Santana PL; Evangelista FF; Beletini LF; Souza AH; Mantelo FM; Souza-Kaneshima AM; Costa IN; Falavigna-Guilherme AL
    Parasitology; 2020 Mar; 147(3):303-309. PubMed ID: 31727196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity evaluation and mode of action of broxaldine on Toxoplasma gondii.
    Qiu Y; Zhai B; Bai Y; Lin H; Wu L; Luo W; Shi M; Chen S; Zhang J
    Int J Parasitol Drugs Drug Resist; 2024 Aug; 25():100552. PubMed ID: 38986389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-
    Teimouri A; Azami SJ; Keshavarz H; Esmaeili F; Alimi R; Mavi SA; Shojaee S
    Int J Nanomedicine; 2018; 13():1341-1351. PubMed ID: 29563791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising
    Esboei BR; Keighobadi M; Hezarjaribi HZ; Fakhar M; Daryani A; Chabra A; Soosaraei M; Yalveh R
    Infect Disord Drug Targets; 2021; 21(1):151-155. PubMed ID: 32389115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of rosuvastatin in tachyzoites of Toxoplasma gondii (RH strain) in HeLa cells.
    Sanfelice RA; Machado LF; Bosqui LR; Miranda-Sapla MM; Tomiotto-Pellissier F; de Alcântara Dalevedo G; Ioris D; Reis GF; Panagio LA; Navarro IT; Bordignon J; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Exp Parasitol; 2017 Oct; 181():75-81. PubMed ID: 28774497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of oral alginate nanoparticles against experimental toxoplasmosis.
    Rashed HA; Abdel-Bary A; Elmorsy EA
    Parasitol Res; 2024 Aug; 123(8):293. PubMed ID: 39105851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Toxoplasma In Vitro and In Vivo Activity of Pyrus boissieriana Arbutin-Rich Fraction.
    Bahreini MS; Pourmohammadi SF; Gholami M; Habibollahi M; Pasdaran A; Hamedi A; Asgari Q
    Acta Parasitol; 2024 Mar; 69(1):567-573. PubMed ID: 38231312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
    Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
    Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
    Andrade RM; Chaparro JD; Capparelli E; Reed SL
    PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo.
    Zhang X; Jin L; Cui Z; Zhang C; Wu X; Park H; Quan H; Jin C
    Exp Parasitol; 2016 Jun; 165():95-102. PubMed ID: 26993085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Propranolol Effect on Experimental Acute and Chronic Toxoplasmosis Using Quantitative PCR.
    Montazeri M; Ebrahimzadeh MA; Ahmadpour E; Sharif M; Sarvi S; Daryani A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7128-7133. PubMed ID: 27645234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Nigella sativa oil on experimental toxoplasmosis.
    Mady RF; El-Hadidy W; Elachy S
    Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.